A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups

Biomaterials

Volumn 33, Issue 26, 2012, Pages 6220-6229

  Srinivas, Ramishetti ^a,b   Garu, Arup ^a   Moku, Gopikrishna ^a   Agawane, Sachin B ^a   Chaudhuri, Arabinda ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antigen presenting cells; Dendritic cell transfection; DNA vaccination; Lipofection

Indexed keywords

ANTIGEN PRESENTING CELLS; CATIONIC AMPHIPHILE; DENDRITIC CELLS; DNA VACCINATION; ELECTROSTATIC COMPLEXES; EX-VIVO; IMMUNE RESPONSE; INFECTIOUS DISEASE; LIPOFECTION; LIPOPLEXES; LONG LASTING; MELANOMA TUMORS; NONVIRAL; PLASMID DNA; SHIKIMIC ACIDS;

AMPHIPHILES; ANTIGENS; CARBOXYLIC ACIDS; CELLS; DNA; IMMUNIZATION; LIPOSOMES; TUMORS; VACCINES; VIRUSES;

MOLECULAR BIOLOGY;

AMPHOPHILE; DENDRITIC CELL VACCINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; LIPOPLEX; LIPOSOME; MANNOSE; N1 [5 AMINO 1 [[2 (1, 1 DIHEXADECYL 1 METHYLAMMONIO) ETHYL]AMINOCARBONYL] PENTYL] 1, 3, 4, 5 TETRAHYDRXY 1 CYCLOHEXANECARBOXAMIDE; N1 [5 AMINO 1 [[2 (1, 1 DIHEXADECYL 1 METHYLAMMONIO) ETHYL]AMINOCARBONYL] PENTYL] 3, 4, 5 TRIHYDRXY 1 CYCLOHEXENE 1 CARBOXAMIDE; PLASMID DNA; QUINIC ACID; SHIKIMIC ACID; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; DENDRITIC CELL; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; EX VIVO STUDY; FEMALE; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MELANOMA; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STATIC ELECTRICITY; TH1 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL LINE, TUMOR; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MANNOSE; MELANOMA; MICE; MICE, INBRED C57BL; TRANSFECTION; VACCINES, DNA;

MUS;

EID: 84862871382     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.006     Document Type: Article

References (29)

1. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 2008, 9:776-788.
2. Santra S., Korber B.T., Muldoon M., Barouch D.H., Nabel G.J., Gao F., et al. A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys. Proc Natl Acad Sci USA 2008, 105:10489-10494.
3. Rice J., Ottensmeier C.H., Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 2008, 8:108-120.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
6. Gilboa E.J. DC-based cancer vaccines. J Clin Investig 2007, 117:1195-1203.
7. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000, 290:92-97.
8. Lapenta C., Santini S.M., Logozzi M., Spada M., Andreotti M., Di Pucchio T., et al. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha. J Exp Med 2003, 198:361-367.
9. Lu W., Wu X., Lu Y., Guo W., Andrieu J.M. Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med 2003, 9:27-32.
10. Lu W., Arraes L.C., Ferreira W.T., Andrieu J.M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med 2004, 10:1359-1365.
11. Tatsumi T., Takehara T., Yamaguchi S., Sasakawa A., Miyagi T., Jinushi M., et al. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity. Gene Ther 2007, 14:863-871.
12. Zabaleta A., Llopiz D., Arribillaga L., Silva L., Riezu-Boj J.I., Lasarte J.J., et al. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein. Mol Ther 2008, 16:210-217.
13. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
14. Srinivas R., Karmali P.P., Pramanik D., Garu A., Mahidhar Y.V., Majeti B.K., et al. Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization. J Med Chem 2010, 53:1387-1391.
15. Kumar V.V., Pichon C., Refregiers M., Guerin B., Midoux P., Chaudhuri A. Single histidine residue in head-group region is sufficient to impart remarkable gene transfection properties to cationic lipids: evidence for histidine-mediated membrane fusion at acidic pH. Gene Ther 2003, 10:1206-1215.
16. Rajesh M., Sen J., Srujan M., Mukherjee K., Sreedhar B., Chaudhuri A. Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery. J Am Chem Soc 2007, 129:11408-11420.
17. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693-1702.
18. McKinney D.M., Skvoretz R., Qin M., Ishioka G., Sette A. Characterization of an in situ IFN-gamma ELISA assay which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunization. J Immunol Methods 2000, 237:105-117.
19. Mockey M., Bourseau E., Chandrashekhar V., Chaudhuri A., Lafosse S., Le Cam E., et al. mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes. Cancer Gene Ther 2007, 14:802-814.
20. Karmali P.P., Kumar V.V., Chaudhuri A. Design, syntheses and in vitro gene delivery efficacies of novel mono-, di- and trilysinated cationic lipids: a structure-activity investigation. J Med Chem 2004, 47:2123-2132.
21. Zhai Y., Yang J.C., Spiess P., Nishimura M.I., Overwijk W.W., Roberts B., et al. Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100. J Immunother 1997, 20:15-25.
22. Coulie P.G., Brichard V., Van Pel A., Wölfel T., Schneider J., Traversari C., et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994, 180:35-42.
23. YKawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Rivoltini L., Topalian S.L., et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994, 91:3515-3519.
24. Kaech S.M., Ahmed R. Immunology. CD8 T cells remember with a little help. Science 2003, 300:263-265.
25. Kawamura K., Kadowaki N., Suzuki R., Udagawa S., Kasaoka S., Utoguchi N., et al. Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity. J Immunother 2006, 29:165-174.
26. Dredge K., Marriott J.B., Todryk S.M., Dalgleish A.G. Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol Immunother 2002, 51:521-531.
27. Irvine A.S., Trinder P.K., Laughton D.L., Ketteringham H., McDermott R.H., Reid C., et al. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nat Biotechnol 2000, 18:1273-1278.
28. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials 2010, 31:7813-7826.
29. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier. Mol Pharm 2011, 8:543-554.